| 09.05 22:30 | dpa-AFX: GNW-Adhoc: DBV Technologies to Participate in Upcoming Investor Conferences |
| 07.05 22:30 | dpa-AFX: GNW-Adhoc: DBV Technologies Reports First Quarter 2024 Financial Results and Business Update |
| 25.04 22:30 | dpa-AFX: GNW-Adhoc: Combined General Meeting of May 16, 2024 |
| 04.04 22:43 | dpa-AFX: GNW-Adhoc: Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024 |
| 08.03 15:33 | dpa-AFX: GNW-Adhoc: DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document |
| 07.03 22:30 | dpa-AFX: GNW-Adhoc: DBV Technologies Reports Full Year 2023 Financial Results and Business Update |
| 04.03 22:30 | dpa-AFX: GNW-Adhoc: DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024 |
| 20.02 22:30 | dpa-AFX: GNW-Adhoc: DBV Technologies to Participate in Upcoming AAAAI 2024 Congress |
| 16.01 22:30 | dpa-AFX: GNW-Adhoc: Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF |
| 04.12 22:30 | dpa-AFX: GNW-Adhoc: Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023 |
| 09.11 22:30 | dpa-AFX: GNW-Adhoc: DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of ViaskinT Peanut in Toddlers |
| 06.11 22:30 | dpa-AFX: GNW-Adhoc: Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023 |
| 02.11 21:30 | dpa-AFX: GNW-Adhoc: DBV Technologies to Present New Data at ACAAI 2023 |
| 31.10 21:30 | dpa-AFX: GNW-Adhoc: DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results |
| 27.10 22:30 | dpa-AFX: GNW-Adhoc: DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update |
| 16.10 08:00 | dpa-AFX: GNW-Adhoc: DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer |
| 05.10 22:30 | dpa-AFX: GNW-Adhoc: Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023 |
| 05.09 22:30 | dpa-AFX: GNW-Adhoc: DBV Technologies to Participate in Upcoming Investor Conference |
| 31.07 22:25 | dpa-AFX: GNW-Adhoc: DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results |
| 25.07 22:30 | dpa-AFX: GNW-Adhoc: DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update |
|
|
